Hugh Shaohim Lin MD MBA
Glaucoma Related, Retinal Disease
Physician
Join to View Full Profile
1 DNA WayNo. 1194South San Francisco, CA 94080
Dr. Lin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Glaucoma, 2008 - 2009
Washington University/B-JH/SLCH ConsortiumResidency, Ophthalmology, 2005 - 2008
Olive View/UCLA Medical CenterInternship, Internal Medicine, 2004 - 2005
Boston University School of MedicineClass of 2004
Certifications & Licensure
CA State Medical License 2008 - 2026
MO State Medical License 2005 - 2008
American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- Intraocular Pressure Outcomes After Lampalizumab Injections in Patients With Geographic Atrophy.Neil M Bressler, K Bailey Freund, Sophie J Bakri, Judy E Kim, Daniela Ferrara
JAMA Ophthalmology. 2024-08-01 - 39 citationsTENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.Arshad M Khanani, Aachal Kotecha, Andrew Chang, Shih-Jen Chen, Youxin Chen
Ophthalmology. 2024-08-01 - 36 citationsFaricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.Tien Y Wong, Zdenka Haskova, Kemal Asik, Caroline R Baumal, Karl G Csaky
Ophthalmology. 2024-06-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
